Your browser doesn't support javascript.
loading
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
Suhler, Eric B; Jaffe, Glenn J; Fortin, Eric; Lim, Lyndell L; Merrill, Pauline T; Dick, Andrew D; Brezin, Antoine P; Nguyen, Quan Dong; Thorne, Jennifer E; Van Calster, Joachim; Cimino, Luca; Adan, Alfredo; Goto, Hiroshi; Kaburaki, Toshikatsu; Kramer, Michal; Vitale, Albert T; Kron, Martina; Song, Alexandra P; Liu, Jianzhong; Pathai, Sophia; Douglas, Kevin M; Schlaen, Ariel; Muccioli, Cristina; Van Velthoven, Mirjam E J; Zierhut, Manfred; Rosenbaum, James T.
Afiliación
  • Suhler EB; Casey Eye Institute, Oregon Health & Science University, OHSU-PSU School of Public Health, and VA Portland Health Care System, Portland, Oregon. Electronic address: suhlere@ohsu.edu.
  • Jaffe GJ; Department of Ophthalmology, Duke University, Durham, North Carolina.
  • Fortin E; Department of Ophthalmology, University of Montreal, Montreal, Canada.
  • Lim LL; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.
  • Merrill PT; Department of Ophthalmology, Rush University Medical Center, Chicago, Illinois.
  • Dick AD; Translational Health Sciences (Ophthalmology), University of Bristol, Bristol Eye Hospital, Bristol, United Kingdom, and National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital and University College London, Institute of Ophthalmology, London, United Kingd
  • Brezin AP; Department of Ophthalmology, Université Paris Descartes, Hôpital Cochin, Paris, France.
  • Nguyen QD; Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California.
  • Thorne JE; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, and Department of Epidemiology, Center for Clinical Trials, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
  • Van Calster J; Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium.
  • Cimino L; Ocular Immunology Unit, Azienda USL IRCCS, Reggio Emilia, Italy.
  • Adan A; Facultad de Medicina, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Goto H; Department of Ophthalmolgy, Medical University, Tokyo, Japan.
  • Kaburaki T; Department of Ophthalmology, University of Tokyo, Tokyo, Japan.
  • Kramer M; Department of Ophthalmology, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Vitale AT; Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah.
  • Kron M; AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany.
  • Song AP; AbbVie, Inc., North Chicago, Illinois.
  • Liu J; AbbVie, Inc., North Chicago, Illinois.
  • Pathai S; Johnson & Johnson Vision, Singapore, Republic of Singapore.
  • Douglas KM; AbbVie, Inc., North Chicago, Illinois.
  • Schlaen A; Department of Ophthalmology, Austral University, Buenos Aires, Argentina.
  • Muccioli C; Department of Ophthalmology and Visual Sciences, Federal University of São Paulo, São Paulo, Brazil.
  • Van Velthoven MEJ; Rotterdam Eye Hospital, Rotterdam, The Netherlands.
  • Zierhut M; Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
  • Rosenbaum JT; Departments of Ophthalmology and Medicine, Oregon Health & Science University and Legacy Devers Eye Institute, Portland, Oregon.
Ophthalmology ; 128(6): 899-909, 2021 06.
Article en En | MEDLINE | ID: mdl-33157077

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Agudeza Visual / Panuveítis / Uveítis Intermedia / Uveítis Posterior / Adalimumab Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Agudeza Visual / Panuveítis / Uveítis Intermedia / Uveítis Posterior / Adalimumab Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Año: 2021 Tipo del documento: Article